Ute Hamann

2.7k total citations
9 papers, 259 citations indexed

About

Ute Hamann is a scholar working on Oncology, Genetics and Immunology. According to data from OpenAlex, Ute Hamann has authored 9 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Genetics and 3 papers in Immunology. Recurrent topics in Ute Hamann's work include Immune Cell Function and Interaction (3 papers), BRCA gene mutations in cancer (2 papers) and Nutrition, Genetics, and Disease (1 paper). Ute Hamann is often cited by papers focused on Immune Cell Function and Interaction (3 papers), BRCA gene mutations in cancer (2 papers) and Nutrition, Genetics, and Disease (1 paper). Ute Hamann collaborates with scholars based in Germany, Sweden and Australia. Ute Hamann's co-authors include Sune Kvist, G J Hämmerling, Hans-Gerhard Burgert, Ursula R. Kees, Bernd Arnold, Peter H. Krammer, Klaus Eichmann, Mohammad Amini, Habibollah Mahmoodzadeh and Mehdi Manoochehri and has published in prestigious journals such as Nature, Cell and The Journal of Immunology.

In The Last Decade

Ute Hamann

9 papers receiving 248 citations

Peers

Ute Hamann
Comparison fields: 5 of 54
  • Immunology 127
  • Molecular Biology 121
  • Genetics 51
  • Cancer Research 49
  • Oncology 44
Replace Susan Kelley with:
Susan Kelley United States
M P Zacheis United States
KL Pogue-Geile United States
Jürgen Bachl Germany
Oleg Osipovich United States
S G Shoemaker United States
Estela Famatiga United States
Justin J. King Canada
Chul-Woo Kim South Korea
Norman R. Ruetsch United States
Susan Kelley United States View profile →
Citations per field, relative to Ute Hamann
Ute Hamann · 1×
Citations per year, relative to Ute Hamann
Ute Hamann · 1×

Countries citing papers authored by Ute Hamann

Since Specialization
Citations

This map shows the geographic impact of Ute Hamann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Hamann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Hamann more than expected).

Fields of papers citing papers by Ute Hamann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ute Hamann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Hamann. The network helps show where Ute Hamann may publish in the future.

Co-authorship network of co-authors of Ute Hamann

This figure shows the co-authorship network connecting the top 25 collaborators of Ute Hamann. A scholar is included among the top collaborators of Ute Hamann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ute Hamann. Ute Hamann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
# Work Indexed citations
1 40
2 15
3 1
4 1
5
Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer.
35
6 53
7 72
8 33
9 9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026